Devajit Mohajan and Haradhan Kumar Mohajan 2023. Metformin: An Oral Anti-Hyperglycaemic Agent for the Treatment of Type 2 Diabetes. Journal of Innovations in Medical Research. 2, 11 (Nov. 2023), 1–8.